Merit Medical Systems Shares Outstanding 2006-2019 | MMSI

Merit Medical Systems shares outstanding from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Merit Medical Systems Annual Shares Outstanding
(Millions of Shares)
2018 54
2017 50
2016 45
2015 45
2014 43
2013 43
2012 43
2011 40
2010 36
2009 36
2008 36
2007 35
2006 35
2005 35
Merit Medical Systems Quarterly Shares Outstanding
(Millions of Shares)
Q3 2019 55
Q2 2019 57
Q1 2019 56
Q4 2018 54
Q3 2018 55
Q2 2018 52
Q1 2018 52
Q4 2017 50
Q3 2017 52
Q2 2017 51
Q1 2017 46
Q4 2016 45
Q3 2016 45
Q2 2016 45
Q1 2016 45
Q4 2015 45
Q3 2015 45
Q2 2015 45
Q1 2015 44
Q4 2014 43
Q3 2014 43
Q2 2014 43
Q1 2014 43
Q4 2013 43
Q3 2013 43
Q2 2013 43
Q1 2013 43
Q4 2012 43
Q3 2012 43
Q2 2012 42
Q1 2012 42
Q4 2011 40
Q3 2011 43
Q2 2011 38
Q1 2011 36
Q4 2010 36
Q3 2010 35
Q2 2010 36
Q1 2010 36
Q4 2009 36
Q3 2009 36
Q2 2009 36
Q1 2009 36
Q4 2008 36
Q3 2008 36
Q2 2008 35
Q1 2008 35
Q4 2007 35
Q3 2007 35
Q2 2007 36
Q1 2007 36
Q4 2006 35
Q3 2006 35
Q2 2006 35
Q1 2006 35
Q4 2005 35
Q3 2005 35
Q2 2005 35
Q1 2005 34
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.259B $0.883B
Merit Medical Systems, Inc. set out to build the world's most customer-focused healthcare company by understanding customers' needs, and innovating and delivering a diverse range of products that improve the lives of people, families, and communities throughout the world. Merit's primary products consist of inflation devices used in angioplasty and stent placement; diagnostic and therapeutic catheters used for various procedures in cardiology and radiology; diagnostic and hydrophilic products used to manage and monitor the administration of contrast media and other fluid solutions; thrombolytic catheters and fluid dispensing systems; and embolotherapeutic products for the treatment of uterine fibroids, hypervascularised tumours, and arteriovenous malformations; and procedural trays, packs, and kits.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $70.565B 22.38
McKesson (MCK) United States $29.730B 11.66
Align Technology (ALGN) United States $21.670B 55.43
AmerisourceBergen (ABC) United States $19.428B 13.03
Laboratory Of America Holdings (LH) United States $18.962B 17.27
Cardinal Health (CAH) United States $17.396B 10.86
Cooper (COO) United States $17.371B 28.61
Straumann Holding AG (SAUHF) Switzerland $15.709B 0.00
West Pharmaceutical Services (WST) United States $12.917B 53.88
DENTSPLY SIRONA (XRAY) United States $12.867B 25.15
Henry Schein (HSIC) United States $10.584B 19.71
CONMED (CNMD) United States $2.976B 39.57
Patterson (PDCO) United States $2.203B 16.32
STAAR Surgical (STAA) United States $1.644B 85.84
Atrion (ATRI) United States $1.268B 34.94
Antares Pharma (ATRS) United States $0.583B 357.00
Invacare (IVC) United States $0.302B 0.00
Lifevantage (LFVN) United States $0.226B 18.93
Pro-Dex (PDEX) United States $0.073B 20.14
Biolase (BIOL) United States $0.021B 0.00
Endologix (ELGX) United States $0.015B 0.00